RESPIRATORIUS
Respiratorius AB develops new effective drugs for cancer, chronic obstructive pulmonary disease (COPD) and severe asthma. The company also runs a project within PET imaging with application in cardiovascular diagnostics. The company is currently conducting clinical development of a drug project (VAL-001), for the treatment of Diffust Large Cell B cell lymphoma. In COPD and asthma, Respiratorius has focused on a new class of patent-pending drug substances, which compared to existing therapies have a superior ability to relax the small airways. The substances, which utilize a new mechanism of action, have been developed via ex-vivo experiments on human lung tissue in the company's proprietary measuring and testing chamber.
RESPIRATORIUS
Industry:
Health Care
Founded:
1998-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.respiratorius.com
Total Employee:
11+
Status:
Active
Contact:
+46 70 922 41 40
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins Global Site Tag
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
TeraImmune
TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders.
Official Site Inspections
http://www.respiratorius.com Semrush global rank: 5.3 M Semrush visits lastest month: 1.56 K
- Host name: webfront1.webcluster.loopia.se
- IP address: 93.188.2.51
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Respiratorius"
Respiratorius – Innovative new drugs
Respiratorius AB (publ) develops candidate drugs with the goal of launching drugs to treat aggressive lymphoma (cancer).See details»
About us - Respiratorius
Since 2012, Respiratorius is a public company listed on the Spotlight Stock Market (formerly Aktietorget). Respiratorius develops effective new drugs to treat aggressive lymphoma …See details»
Board of Directors and CEO – Respiratorius
Karin has extensive experience in corporate governance, corporate strategy, and financial management. Within healthcare, she is the co-founder and has served as the Chairman of the Board for 10 years of EQL Pharma AB and been …See details»
Respiratorius AB (publ) - Crunchbase Company Profile & Funding
Respiratorius AB (publ) is the developer of new effective drugs for cancer, chronic obstructive pulmonary disease (COPD) and severe asthma. View contacts for Respiratorius AB (publ) to …See details»
Respiratorius AB - LinkedIn
Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer and especially aggressive lymphoma. The company was originally …See details»
Respiratorius Company Profile - Office Locations, Competitors
Respiratorius is a company that develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and severe asthma. It develops drugs supporting the …See details»
Respiratorius AB (publ), RESP:AKT profile - FT.com - Financial Times
Nov 12, 2024 · Respiratorius AB (publ) is a Sweden-based biotechnology and pharmaceutical company. It develops candidate drugs for treatment of cancer, Chronic Obstructive Pulmonary …See details»
Respiratorius AB (publ), HF0:FRA profile - FT.com - Financial Times
Nov 5, 2024 · Respiratorius AB (publ) (HF0:FRA) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Respiratorius AB - VentureRadar
Website: http://www.respiratorius.com. Respiratorius AB (publ) develops drug candidates with the goal of launching drugs to treat common diseases such as cancer, chronic obstructive …See details»
2020 - respiratorius.com
2020 ANNUAL REPORT FOR RESPIRATORIUS AB 4 Respiratorius in brief BUSINESS CONCEPT Respiratorius develops effective new drugs to treat the common diseases cancer, …See details»
Respiratorius CEO: “We continue to reduce risk in the project”
Nov 15, 2024 · – We have a clear strategy to clarify and strengthen the company’s values as well as a clear regulatory strategy, says Johan Drott to BioStock. Lund-based Respiratorius is …See details»
RESP Stock Price Quote - Morningstar
See the latest Respiratorius AB stock price (RESP:XSAT), related news, valuation, dividends and more to help you make your investing decisions.See details»
Arcede Pharma – develops drug candidates
Jan 12, 2024 · Arcede aims at being an attractive partner for academic research groups, biotech companies and global pharmaceutical companies with expertise positioned all along the drug …See details»
Respiratorius - Products, Competitors, Financials, Employees ...
Respiratorius operates as a pharmaceutical company. It develops drugs for the treatment of aggressive lymphoma, specifically diffuse large B-cell lymphoma. The company offers drug …See details»
Respiratorius' H1 marked by positive patent decision and secured ...
Aug 13, 2024 · Respiratorius is developing the drug candidate VAL001 with the aim of improving the treatment of diffuse large B-cell lymphoma (DLBCL), an aggressive form of lymph node …See details»
Financial Reports – Respiratorius
Respiratorius AB (publ) develops candidate drugs with the goal of launching drugs to treat aggressive lymphoma (cancer).See details»
Respiratorius aktie (RESP) - Dagens industri
Senaste nytt om Respiratorius aktie. Respiratorius komplett bolagsfakta från Di.se Informationen är fördröjd med 15 minuter och levereras av Millistream.See details»
Respirator - Wikipedia
A respirator is a device designed to protect the wearer from inhaling hazardous atmospheres including lead fumes, vapors, gases and particulate matter such as dusts and airborne …See details»
Respiratorius Q3 2021 FINAL-en-US
Interim report 3, 2021 | Respiratorius AB (publ), corporate identity number: 556552-2652 Respiratorius Operations Respiratorius AB (publ) develops drug candidates with the goal of …See details»
Respiratory system: Anatomy and functions - Kenhub
Oct 30, 2023 · The respiratory system, also called the pulmonary system, consists of several organs that function as a whole to oxygenate the body through the process of respiration …See details»